Migraine pill could help spinal cord injury recovery
NCT ID NCT06677229
Summary
This early-stage trial is testing whether a drug already used for migraines (Eletriptan, called TZ-161 in this study) can help people recover from a recent, traumatic spinal cord injury. The goal is to see if the drug is safe and well-tolerated in this new situation and to gather early signs of whether it might improve movement. The study will enroll about 28 adults with a specific type of injury in the upper to middle back, who can receive the first dose within 24 hours of their injury.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.